Demaria, Sandra
Weill Cornell Medicine,
United States
2025 Rank: 20510
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 610 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20510 | 22887 |
| Total Cites | 2838 | 3056 |
| H-index | 29 | 29 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 304 | 315 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 1247 | 1273 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1883 | 1978 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.54 |
| Self-Citation Percentage |
7.13%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2024 Rank: 14107
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 453 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14107 | 14991 |
| Total Cites | 3345 | 3630 |
| H-index | 31 | 32 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 401 | 414 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 1514 | 1580 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2050 | 2140 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.70 |
| Self-Citation Percentage |
7.85%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2023 Rank: 15792
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 578 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15792 | 16871 |
| Total Cites | 3290 | 3577 |
| H-index | 30 | 31 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 360 | 367 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 1429 | 1478 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2054 | 2153 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.66 |
| Self-Citation Percentage |
8.02%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2022 Rank: 11498
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 440 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11498 | 11932 |
| Total Cites | 3572 | 3948 |
| H-index | 32 | 34 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 482 | 495 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 1737 | 1821 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2063 | 2183 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.81 |
| Self-Citation Percentage |
9.52%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2021 Rank: 14844
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 544 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14844 | 15749 |
| Total Cites | 5170 | 5707 |
| H-index | 37 | 39 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 694 | 718 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 2571 | 2737 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2931 | 3096 |
| Ratio of Total Citations to Distinct Citing Papers | 1.76 | 1.84 |
| Self-Citation Percentage |
9.41%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2020 Rank: 16268
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 583 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16268 | 17126 |
| Total Cites | 3131 | 3503 |
| H-index | 30 | 33 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 466 | 482 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 1567 | 1682 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1801 | 1920 |
| Ratio of Total Citations to Distinct Citing Papers | 1.74 | 1.82 |
| Self-Citation Percentage |
10.62%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.